Atlas Trials

Targeting Pulmonary Perfusion in Alpha-1 Antitrypsin Deficiency

Clinical trial NCT03008915 · COMPLETED

Trial details

NCT number
NCT03008915
Sponsor
Columbia University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Alpha-1 Antitrypsin DeficiencyEmphysemaChronic Obstructive Pulmonary Disease
Start date
2017-01-01
Primary completion
2018-07-01
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.